Figure 11.

BMNs for photothermal therapy. (a) Schematic diagram of composition of Au–Ag@PDA. Reprinted with permission from Ref. [126]. (b) The temporal temperature variation of the branched Au–Ag NPs. Reprinted with permission from Ref. [126]. (c) Hela cell viabilities after 808 nm laser irradiation with different power densities for 10 min. Reprinted with permission from Ref. [126]. Copyright © 2015 American Chemical Society. (d) The photothermal therapeutic of Au@Pt nanostructures. Reprinted with permission from Ref. [127]. Copyright © The Royal Society of Chemistry 2014. (e) Strategy for HAAA-NUs synthesis and functionalization. Reprinted with permission from Ref. [128]. (f) Photothermal effect of HAAA-NUs. Reprinted with permission from Ref. [128]. (g,h) In vivo photothermal tumor therapy ((g) IR thermal images of tumor-bearing mice with laser irradiation, L-laser on, LO-laser off. (h) The tumor volumes after different treatments). Reprinted with permission from Ref. [128]. Copyright © 2014 Elsevier Ltd. (i) Synergistic photothermal-catalytic therapy of CeO₂/Au@Pt-PEG. Reprinted with permission from Ref. [129]. (j) The therapeutic effect of CeO₂/Au@Pt-PEG on tumors in vitro and in vivo (Relative tumor volume: (1) PBS, (2) NIR, (3) CeO₂/Au@Pt-PEG, (4) Au@Pt-PEG + NIR, (5) CeO₂/Au@Pt-PEG + NIR). Reprinted with permission from Ref. [125]. Copyright © 2022 Elsevier B.V. ** p < 0.01, *** p < 0.001.